Industry-Specific Oracle Application Bundles Help to Accelerate Best-Practice Implementations and Return On Investment

REDWOOD SHORES, Calif. - Oracle today announced that Oracle Certified and Certified Advantage Partners worldwide have introduced seven new Oracle Accelerate solutions tailored to the unique needs of the life sciences industry. These Oracle-reviewed solutions feature pre-packaged application bundles and a wide range of industry-specific functionality designed to help rapidly growing life science organizations quickly and affordably implement Oracle(r) Applications. Since August 2007, Oracle partners have launched a total of 15 Oracle Accelerate solutions dedicated to the life sciences industry.

"Emerging life sciences organizations face the same clinical trial and regulatory requirements as larger, more established players in the field. They also require enterprise-class applications to manage these functions effectively, but frequently face significant time and resource constraints," said Torsten Adam, Managing Director, pharmasol. "Our Oracle Accelerate solutions are already having a substantial impact on the growth and evolution of our business. As a result, we are winning a greater percentage of deals because of our ability to offer a complete, pre-configured solution that speeds implementation time while providing scalability and an upgrade path to support customers as they grow."

Oracle Accelerate solutions combine Oracle's enterprise-class applications with partner expertise and rapid implementation tools in industry-tailored solutions that are specifically packaged, priced and designed by partners for easy ownership by midsize businesses and government entities. Fundamental to the Oracle Accelerate program is pre-packaged application bundles that allow for rapid, best-practice implementations.

"Fast-growing life sciences organizations require robust, affordable and easy-to-implement solutions to help them meet industry-specific requirements, ranging from streamlining management of complex clinical trials to ensuring efficiency of supply chain, manufacturing and sales processes," said Dennis Constantinou, Oracle Senior Director, Life Sciences. "Oracle Accelerate solutions for life sciences meet these needs by allowing partners to provide bundled and pre-configured applications and services tailored to industry best practices. This approach helps life sciences organizations reduce costs, accelerate implementation and return on investment and focus resources on core business operations."

Oracle Accelerate solutions are delivered by partners with a proven history of serving a customer's specific industry and geography. Oracle also reviews Oracle Accelerate solutions before accepting them into the program, giving customers confidence that the solutions will be easy to implement and provide a proven upgrade path.

Partners Focus on Life Sciences Offerings

The following partners have introduced Oracle Accelerate solutions for the life sciences industry:
* Abaris (United States): Oracle Accelerate for Medical Device
* BPI (United States): Oracle Accelerate for Pharmaceutical
* Business Decision (United States): Oracle Accelerate for Pharmaceutical
* e-Frontech (France): Oracle Accelerate for Pharmaceutical
* Fusion 5 (Australia): Oracle Accelerate for Life Science
* Intelligroup (United States): Oracle Accelerate for Pharmaceutical
* Percipient (United Kingdom): Oracle Accelerate for Pharmaceutical
* pharmasol (France): Oracle Accelerate for Oracle Clinical Solution
* pharmasol (Germany): Oracle Accelerate for Oracle Clinical Solution
* Pyxis Consulting Group GmbH(Germany): Oracle Accelerate for Biotech
* Pyxis Consulting Group GmbH (Germany): Oracle Accelerate for Medical Device
* Solbourne (United States): Oracle Accelerate for Biotech
* Wilus (Korea): Oracle Accelerate for Pharmaceutical
* Zannett (United States): Oracle Accelerate for Pharmaceutical
* Zannett (United States): Oracle Accelerate for Medical Device